These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 9824326)
21. Rapid epidemic spread of HIV type 1 subtype A1 among intravenous drug users in Latvia and slower spread of subtype B among other risk groups. Balode D; Ferdats A; Dievberna I; Viksna L; Rozentale B; Kolupajeva T; Konicheva V; Leitner T AIDS Res Hum Retroviruses; 2004 Feb; 20(2):245-9. PubMed ID: 15018713 [TBL] [Abstract][Full Text] [Related]
22. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Zhu T; Mo H; Wang N; Nam DS; Cao Y; Koup RA; Ho DD Science; 1993 Aug; 261(5125):1179-81. PubMed ID: 8356453 [TBL] [Abstract][Full Text] [Related]
23. Genetic characterization of HIV type 1 gag p17 matrix genes in isolates from infected mothers lacking perinatal transmission. Hahn T; Ahmad N AIDS Res Hum Retroviruses; 2001 Nov; 17(17):1673-80. PubMed ID: 11779356 [TBL] [Abstract][Full Text] [Related]
24. Characterization of human immunodeficiency virus type 1 p17 matrix protein motifs associated with mother-to-child transmission. Narwa R; Roques P; Courpotin C; Parnet-Mathieu F; Boussin F; Roane A; Marce D; Lasfargues G; Dormont D J Virol; 1996 Jul; 70(7):4474-83. PubMed ID: 8676472 [TBL] [Abstract][Full Text] [Related]
25. Env gene characterization of the first HIV type 1 group O Spanish isolate. Mas A; Quiñones-Mateu E; Soriano V; Domingo E AIDS Res Hum Retroviruses; 1996 Nov; 12(17):1647-9. PubMed ID: 8947302 [No Abstract] [Full Text] [Related]
26. Human immunodeficiency virus type 1 env and p17gag sequence variation in polymerase chain reaction-positive, seronegative injection drug users. Markham RB; Yu X; Farzadegan H; Ray SC; Vlahov D J Infect Dis; 1995 Apr; 171(4):797-804. PubMed ID: 7706805 [TBL] [Abstract][Full Text] [Related]
27. Timing and reconstruction of the most recent common ancestor of the subtype C clade of human immunodeficiency virus type 1. Travers SA; Clewley JP; Glynn JR; Fine PE; Crampin AC; Sibande F; Mulawa D; McInerney JO; McCormack GP J Virol; 2004 Oct; 78(19):10501-6. PubMed ID: 15367616 [TBL] [Abstract][Full Text] [Related]
28. The HIV type 1 epidemic in Belarus: predominance of Eastern European subtype A strains and circulation of subtype B viruses. Lazouskaya NV; Eremin VF; Adema KW; Gasich EL; Baan E; Lukashov VV AIDS Res Hum Retroviruses; 2005 Sep; 21(9):830-3. PubMed ID: 16218809 [TBL] [Abstract][Full Text] [Related]
30. Inhibitory mechanism of anti-P30-52 monoclonal antibody against human immunodeficiency virus type 1 (HIV-1) multiplication in infected MT-4 cells. Ota A; Ueda S Hybridoma; 1999 Jun; 18(3):235-41. PubMed ID: 10475237 [TBL] [Abstract][Full Text] [Related]
31. Polymorphism of HIV-1 gag (p17) gene from female sex workers in Calcutta, India. Sengupta S; Khetawat D; Jana S; Sarkar K; Bhattacharya SK; Chakrabarti S Arch Virol; 2005 Oct; 150(10):2117-24. PubMed ID: 15959835 [TBL] [Abstract][Full Text] [Related]
32. Sequence analysis of selected regions of the env (V3 loop and gp41) and gag (p7) reading frames of Ethiopian human immunodeficiency virus type 1 strains. Ayehunie S; Johansson B; Sönnerborg A; Zewdie DW; Britton S; Strannegård O Arch Virol; 1993; 128(3-4):229-39. PubMed ID: 8435043 [TBL] [Abstract][Full Text] [Related]
33. Correlation between HIV sequence evolution, specific immune response and clinical outcome in vertically infected infants. Halapi E; Leitner T; Jansson M; Scarlatti G; Orlandi P; Plebani A; Romiti L; Albert J; Wigzell H; Rossi P AIDS; 1997 Nov; 11(14):1709-17. PubMed ID: 9386805 [TBL] [Abstract][Full Text] [Related]
34. Potential impact of viral load and genetic makeup of HIV type 1 on mother-to-child transmission: characterization of env-C2V3C3 and nef sequences. Pádua E; Parreira R; Tendeiro R; Nunes B; Castela J; Soares I; Mouzinho A; Reis E; Paixão MT AIDS Res Hum Retroviruses; 2009 Nov; 25(11):1171-7. PubMed ID: 19886833 [TBL] [Abstract][Full Text] [Related]
35. Coexistence of subtypes B, F, and as B/F env recombinant of HIV type 1 in Buenos Aires Argentina. Marquina S; Leitner T; Rabinovich RD; Benetucci J; Libonatti O; Albert J AIDS Res Hum Retroviruses; 1996 Nov; 12(17):1651-4. PubMed ID: 8947303 [No Abstract] [Full Text] [Related]
36. Genetic analysis of HIV-1 isolates from Brazil reveals presence of two distinct genetic subtypes. Louwagie J; Delwart EL; Mullins JI; McCutchan FE; Eddy G; Burke DS AIDS Res Hum Retroviruses; 1994 May; 10(5):561-7. PubMed ID: 7917518 [TBL] [Abstract][Full Text] [Related]
37. Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C. Gómez CE; Nájera JL; Jiménez V; Bieler K; Wild J; Kostic L; Heidari S; Chen M; Frachette MJ; Pantaleo G; Wolf H; Liljeström P; Wagner R; Esteban M Vaccine; 2007 Mar; 25(11):1969-92. PubMed ID: 17224219 [TBL] [Abstract][Full Text] [Related]
38. p17gag sequence of HIV-1GER, a new, highly replicative and highly cytopathic HIV type 1 strain of D genotype. Emiliani S; Blanc M; Devaux C AIDS Res Hum Retroviruses; 1994 Aug; 10(8):1043-5. PubMed ID: 7811536 [No Abstract] [Full Text] [Related]
39. Molecular approaches to AIDS vaccine development using baculovirus expression vectors. Kang CY Methods Mol Biol; 1995; 39():295-315. PubMed ID: 7542523 [No Abstract] [Full Text] [Related]
40. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles. Kang CY; Luo L; Wainberg MA; Li Y Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]